Menu
Back to Journals » OncoTargets and Therapy
OncoTargets and Therapy
ISSN: 1178-6930
Editor-in-Chief: Professor Gaetano Romano
OncoTargets and Therapy is an international, peer-reviewed journal focusing on the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer. This journal explores the evidence behind new and existing therapies to aid their informed acceptance by clinicians and treatment adherence by patients.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (6510)
- Volume 17, 2024 (72)
- Volume 16, 2023 (147)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Latest articles:
- 5 records -
Red Sea Sponge Callyspongia siphonella Extract Induced Growth Inhibition and Apoptosis in Breast MCF-7 and Hepatic HepG-2 Cancer Cell Lines in 2D and 3D Cell Cultures
Fadil SA, Aljoud FA, Yonbawi AR, Almalki AJ, Hareeri RH, Ashi A, AlQriqri MA, Bawazir NS, Alshangiti HH, Shaala LA, Youssef DTA, Alkhilaiwi FA
OncoTargets and Therapy 2024, 17:521-536
Published Date: 25 June 2024
Impact of Combined Chemotherapy and Targeted Therapy on Pancreatic Neuroendocrine Carcinoma with Liver Metastasis: A Single-Center Modified Nomogram Analysis
Luo W, Chen H, Zhang T
OncoTargets and Therapy 2024, 17:509-519
Published Date: 22 June 2024
Combined Dacomitinib and Selpercatinib Treatment for a Patient with EGFR-Mutant Non-Small Cell Lung Cancer and Acquired CCDC6-RET Fusion
Liu CY, Liu CH
OncoTargets and Therapy 2024, 17:499-506
Published Date: 18 June 2024
Prolonged Clinical Benefit with Futibatinib in a Patient with FGFR Inhibitor–Pretreated FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma: Case Report
d'Arienzo PD, MacDonald AR, Patel V, Ma YT, Pihlak R, Starling N
OncoTargets and Therapy 2024, 17:489-496
Published Date: 13 June 2024
Unraveling the Mechanism of Curculiginis Rhizoma in Suppressing Cisplatin Resistance in Non-Small Cell Lung Cancer: An Experimental Study
Huang X, Wang M, Zhu B, Hao Y, Gao R, Liu W, Cheng J, Hua G, Xue C
OncoTargets and Therapy 2024, 17:471-487
Published Date: 12 June 2024